Related Experiment Videos
Hereditary C6 deficiency in man
Summary
This study identifies the first human kindred with complement component 6 (C6) deficiency, a condition inherited in an autosomal pattern. Homozygous C6 deficiency in humans does not impair chemotaxis or coagulation.
Area of Science:
- Immunology
- Genetics
- Complement System
Background:
- The complement system is crucial for innate and adaptive immunity.
- Complement component 6 (C6) is essential for the formation of the membrane attack complex (MAC).
- Deficiencies in complement components can lead to increased susceptibility to infections and autoimmune diseases.
Purpose of the Study:
- To characterize a novel case of complement component 6 (C6) deficiency in a human.
- To investigate the inheritance pattern and functional consequences of C6 deficiency in a human kindred.
- To compare C6 deficiency in humans with previously studied animal models.
Main Methods:
- Serum CH50 titrations and functional assays for all complement components.
- Detection of C6 deficiency using functional assays and antigenic analysis with monospecific anti-C6 antibody.
- Assessment of bactericidal activity, neutrophil chemotaxis, immune adherence, and PNH red cell lysis.
- Genetic analysis of the affected kindred to determine inheritance patterns.
Main Results:
- A 18-year-old female presented with undetectable C6 levels in serum and plasma.
- Hemolytic activity was restored upon addition of purified C6.
- Parents and 5 out of 6 siblings exhibited approximately half-normal C6 levels, indicating autosomal inheritance.
- The C6-deficient individual showed absent bactericidal activity and PNH red cell lysis but normal chemotaxis and coagulation functions.
Conclusions:
- This study documents the first human kindred with complement component 6 (C6) deficiency.
- C6 deficiency in humans follows a classic Mendelian autosomal inheritance pattern.
- Unlike C6-deficient rabbits, homozygous C6 deficiency in humans does not affect chemotactic or coagulation functions.